Most research on the autophagy-lysosome pathway (ALP) in neurodegeneration is stuck using vague descriptors like "impaired," "enlarged," or "reduced." These terms don't provide the statistical rigor we need for clinical translation. While lysosomal dysfunction clearly drives proteostatic failure in AD and PD PMC12786279, we're still fixated on static markers like LC3-II puncta. These offer no real insight into kinetic flux. It’s like trying to diagnose a traffic jam by looking at a single grainy photograph of a highway.

I suspect the real driver of proteostatic collapse in aging isn't just a drop in mean lysosomal activity, but Lysosomal Hysteresis: a progressive increase in the phase-lag between mTORC1 signaling and V-ATPase-mediated acidification cycles.

Lysosomal pH shouldn't be viewed as a static state, but as a rhythmic oscillator (Thread: 2026-03-11). In healthy cells, mTORC1 recruitment to the lysosomal membrane is precisely timed to nutrient availability. In senescent cells, however, mTORC1 becomes constitutively active and loses its sensitivity to starvation JCB.201610113. This leads to temporal decoupling. The lysosome’s acidification cycle loses its amplitude because the nuclear dilution of TFEB—driven by nuclear volume expansion—flattens the transcriptional bursts required to assemble V-ATPase (Thread: 2026-03-11).

This explains why mTOR inhibitors like rapamycin often underperform in aged tissues. If the underlying pathology is a loss of oscillatory frequency—essentially a "flat-lined" pH—simply lowering the baseline mTORC1 signal won't restore the rhythm. This is where mTOR-independent activators like CCT020312 matter. CCT020312 can clear aggregates in a dose-dependent manner bioRxiv 2022.09.29.509997, likely because it bypasses the broken mTORC1 clock and imposes a synthetic pulse of lysosomal biogenesis.

To move beyond qualitative guesswork, we need to quantify the Oscillatory Flux Coefficient (OFC). I predict that:

1. Phase Shift: In senescent fibroblasts, the time-delay between mTORC1 dissociation and the lysosome reaching pH <4.5 will increase by more than 300% compared to young controls.
2. Amplitude Decay: Peak-to-trough pH variance in aged neurons will show a fold-reduction proportional to p62-positive aggregate accumulation. This would give us a quantitative threshold for proteostatic collapse.
3. Rescue: Successful interventions, such as CCT020312, won't just "lower pH" but will restore the frequency of acidification cycles to within 15% of juvenile baselines.

Until we stop publishing "impaired" and start publishing hertz and phase-angles, our understanding of the ALP will remain a collection of anecdotes rather than a predictive science.